nodes	percent_of_prediction	percent_of_DWPC	metapath
Dorzolamide—CYP3A4—type 2 diabetes mellitus	0.188	1	CbGaD
Dorzolamide—CYP2C9—Glimepiride—type 2 diabetes mellitus	0.0395	0.0821	CbGbCtD
Dorzolamide—CYP2C9—Glipizide—type 2 diabetes mellitus	0.0361	0.0751	CbGbCtD
Dorzolamide—CYP2C9—Gliclazide—type 2 diabetes mellitus	0.0336	0.0698	CbGbCtD
Dorzolamide—CYP2C9—Chlorpropamide—type 2 diabetes mellitus	0.0285	0.0594	CbGbCtD
Dorzolamide—CYP2C9—Pioglitazone—type 2 diabetes mellitus	0.0285	0.0594	CbGbCtD
Dorzolamide—CYP2C9—Rosiglitazone—type 2 diabetes mellitus	0.0263	0.0548	CbGbCtD
Dorzolamide—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0257	0.0536	CbGbCtD
Dorzolamide—CYP2C9—Tolbutamide—type 2 diabetes mellitus	0.0254	0.0529	CbGbCtD
Dorzolamide—CYP2C9—Valsartan—type 2 diabetes mellitus	0.0233	0.0484	CbGbCtD
Dorzolamide—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0229	0.0478	CbGbCtD
Dorzolamide—CYP2C9—Nateglinide—type 2 diabetes mellitus	0.0216	0.045	CbGbCtD
Dorzolamide—CYP3A4—Glipizide—type 2 diabetes mellitus	0.021	0.0437	CbGbCtD
Dorzolamide—CYP2C9—Irbesartan—type 2 diabetes mellitus	0.0207	0.0431	CbGbCtD
Dorzolamide—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.0183	0.0382	CbGbCtD
Dorzolamide—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.0166	0.0345	CbGbCtD
Dorzolamide—CYP2C9—Glyburide—type 2 diabetes mellitus	0.0146	0.0304	CbGbCtD
Dorzolamide—CYP2C9—Losartan—type 2 diabetes mellitus	0.0134	0.0278	CbGbCtD
Dorzolamide—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.0126	0.0262	CbGbCtD
Dorzolamide—CYP3A4—Orlistat—type 2 diabetes mellitus	0.0121	0.0251	CbGbCtD
Dorzolamide—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.0121	0.0251	CbGbCtD
Dorzolamide—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.0114	0.0237	CbGbCtD
Dorzolamide—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00849	0.0177	CbGbCtD
Dorzolamide—CYP3A4—Losartan—type 2 diabetes mellitus	0.00777	0.0162	CbGbCtD
Dorzolamide—CA1—nerve—type 2 diabetes mellitus	0.00183	0.0854	CbGeAlD
Dorzolamide—CA9—islet of Langerhans—type 2 diabetes mellitus	0.00151	0.0706	CbGeAlD
Dorzolamide—CA4—nerve—type 2 diabetes mellitus	0.00143	0.0667	CbGeAlD
Dorzolamide—Brinzolamide—CYP3A4—type 2 diabetes mellitus	0.00128	1	CrCbGaD
Dorzolamide—CA7—kidney—type 2 diabetes mellitus	0.00122	0.0568	CbGeAlD
Dorzolamide—CA5A—liver—type 2 diabetes mellitus	0.00116	0.054	CbGeAlD
Dorzolamide—CA12—kidney—type 2 diabetes mellitus	0.000792	0.0369	CbGeAlD
Dorzolamide—CA5B—cardiovascular system—type 2 diabetes mellitus	0.000726	0.0339	CbGeAlD
Dorzolamide—CA5B—pancreas—type 2 diabetes mellitus	0.000705	0.0329	CbGeAlD
Dorzolamide—CA4—islet of Langerhans—type 2 diabetes mellitus	0.000693	0.0323	CbGeAlD
Dorzolamide—CA14—liver—type 2 diabetes mellitus	0.000642	0.0299	CbGeAlD
Dorzolamide—CA1—cardiovascular system—type 2 diabetes mellitus	0.000641	0.0299	CbGeAlD
Dorzolamide—CA5B—adipose tissue—type 2 diabetes mellitus	0.00064	0.0299	CbGeAlD
Dorzolamide—CA1—kidney—type 2 diabetes mellitus	0.000627	0.0293	CbGeAlD
Dorzolamide—CA1—pancreas—type 2 diabetes mellitus	0.000623	0.0291	CbGeAlD
Dorzolamide—CA2—islet of Langerhans—type 2 diabetes mellitus	0.000574	0.0268	CbGeAlD
Dorzolamide—CA1—adipose tissue—type 2 diabetes mellitus	0.000565	0.0264	CbGeAlD
Dorzolamide—CA4—nephron tubule—type 2 diabetes mellitus	0.000558	0.026	CbGeAlD
Dorzolamide—CA4—cardiovascular system—type 2 diabetes mellitus	0.000501	0.0234	CbGeAlD
Dorzolamide—CA2—retina—type 2 diabetes mellitus	0.000491	0.0229	CbGeAlD
Dorzolamide—CA4—kidney—type 2 diabetes mellitus	0.00049	0.0229	CbGeAlD
Dorzolamide—CA4—cortex of kidney—type 2 diabetes mellitus	0.000477	0.0223	CbGeAlD
Dorzolamide—CA2—nephron tubule—type 2 diabetes mellitus	0.000462	0.0216	CbGeAlD
Dorzolamide—CA4—adipose tissue—type 2 diabetes mellitus	0.000442	0.0206	CbGeAlD
Dorzolamide—CA2—cardiovascular system—type 2 diabetes mellitus	0.000415	0.0194	CbGeAlD
Dorzolamide—CA2—kidney—type 2 diabetes mellitus	0.000406	0.019	CbGeAlD
Dorzolamide—CA2—pancreas—type 2 diabetes mellitus	0.000404	0.0188	CbGeAlD
Dorzolamide—CA1—liver—type 2 diabetes mellitus	0.000396	0.0185	CbGeAlD
Dorzolamide—CA2—cortex of kidney—type 2 diabetes mellitus	0.000396	0.0185	CbGeAlD
Dorzolamide—CA2—adipose tissue—type 2 diabetes mellitus	0.000366	0.0171	CbGeAlD
Dorzolamide—CYP2C9—cardiovascular system—type 2 diabetes mellitus	0.000351	0.0164	CbGeAlD
Dorzolamide—CYP3A4—kidney—type 2 diabetes mellitus	0.000262	0.0122	CbGeAlD
Dorzolamide—CA2—liver—type 2 diabetes mellitus	0.000257	0.012	CbGeAlD
Dorzolamide—CYP2C9—liver—type 2 diabetes mellitus	0.000217	0.0101	CbGeAlD
Dorzolamide—CYP3A4—liver—type 2 diabetes mellitus	0.000166	0.00773	CbGeAlD
Dorzolamide—Anorexia—Valsartan—type 2 diabetes mellitus	0.000154	0.000694	CcSEcCtD
Dorzolamide—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000154	0.000693	CcSEcCtD
Dorzolamide—Chest pain—Metformin—type 2 diabetes mellitus	0.000154	0.000692	CcSEcCtD
Dorzolamide—Vertigo—Irbesartan—type 2 diabetes mellitus	0.000153	0.000689	CcSEcCtD
Dorzolamide—Headache—Pioglitazone—type 2 diabetes mellitus	0.000153	0.000688	CcSEcCtD
Dorzolamide—Syncope—Irbesartan—type 2 diabetes mellitus	0.000153	0.000688	CcSEcCtD
Dorzolamide—Visual impairment—Ramipril—type 2 diabetes mellitus	0.000152	0.000685	CcSEcCtD
Dorzolamide—Discomfort—Metformin—type 2 diabetes mellitus	0.000152	0.000684	CcSEcCtD
Dorzolamide—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000152	0.000683	CcSEcCtD
Dorzolamide—Nausea—Glipizide—type 2 diabetes mellitus	0.000151	0.000681	CcSEcCtD
Dorzolamide—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000151	0.000681	CcSEcCtD
Dorzolamide—Hypotension—Valsartan—type 2 diabetes mellitus	0.000151	0.000681	CcSEcCtD
Dorzolamide—Vision blurred—Losartan—type 2 diabetes mellitus	0.000151	0.00068	CcSEcCtD
Dorzolamide—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000151	0.000678	CcSEcCtD
Dorzolamide—Pain—Gliclazide—type 2 diabetes mellitus	0.000151	0.000678	CcSEcCtD
Dorzolamide—Rash—Glimepiride—type 2 diabetes mellitus	0.00015	0.000675	CcSEcCtD
Dorzolamide—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.00015	0.000674	CcSEcCtD
Dorzolamide—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	0.00015	0.000674	CcSEcCtD
Dorzolamide—Rash—Sitagliptin—type 2 diabetes mellitus	0.000149	0.000673	CcSEcCtD
Dorzolamide—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000149	0.000672	CcSEcCtD
Dorzolamide—Erythema multiforme—Ramipril—type 2 diabetes mellitus	0.000149	0.000672	CcSEcCtD
Dorzolamide—Headache—Glimepiride—type 2 diabetes mellitus	0.000149	0.000671	CcSEcCtD
Dorzolamide—Cough—Irbesartan—type 2 diabetes mellitus	0.000149	0.000669	CcSEcCtD
Dorzolamide—Headache—Sitagliptin—type 2 diabetes mellitus	0.000149	0.000668	CcSEcCtD
Dorzolamide—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.000147	0.000664	CcSEcCtD
Dorzolamide—Oedema—Metformin—type 2 diabetes mellitus	0.000147	0.000663	CcSEcCtD
Dorzolamide—Tinnitus—Ramipril—type 2 diabetes mellitus	0.000147	0.000663	CcSEcCtD
Dorzolamide—Hypertension—Irbesartan—type 2 diabetes mellitus	0.000147	0.000662	CcSEcCtD
Dorzolamide—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000147	0.000661	CcSEcCtD
Dorzolamide—Angioedema—Losartan—type 2 diabetes mellitus	0.000147	0.000659	CcSEcCtD
Dorzolamide—Insomnia—Valsartan—type 2 diabetes mellitus	0.000146	0.000659	CcSEcCtD
Dorzolamide—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.000146	0.000656	CcSEcCtD
Dorzolamide—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.000145	0.000654	CcSEcCtD
Dorzolamide—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000145	0.000653	CcSEcCtD
Dorzolamide—Chest pain—Irbesartan—type 2 diabetes mellitus	0.000145	0.000653	CcSEcCtD
Dorzolamide—Arthralgia—Irbesartan—type 2 diabetes mellitus	0.000145	0.000653	CcSEcCtD
Dorzolamide—Shock—Metformin—type 2 diabetes mellitus	0.000145	0.000653	CcSEcCtD
Dorzolamide—Insomnia—Orlistat—type 2 diabetes mellitus	0.000145	0.000651	CcSEcCtD
Dorzolamide—Anxiety—Irbesartan—type 2 diabetes mellitus	0.000145	0.000651	CcSEcCtD
Dorzolamide—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000145	0.00065	CcSEcCtD
Dorzolamide—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000144	0.000649	CcSEcCtD
Dorzolamide—Vertigo—Losartan—type 2 diabetes mellitus	0.000144	0.000648	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000144	0.000648	CcSEcCtD
Dorzolamide—Somnolence—Valsartan—type 2 diabetes mellitus	0.000144	0.000647	CcSEcCtD
Dorzolamide—Syncope—Losartan—type 2 diabetes mellitus	0.000144	0.000647	CcSEcCtD
Dorzolamide—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000144	0.000646	CcSEcCtD
Dorzolamide—Discomfort—Irbesartan—type 2 diabetes mellitus	0.000143	0.000645	CcSEcCtD
Dorzolamide—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.000142	0.000641	CcSEcCtD
Dorzolamide—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000142	0.000641	CcSEcCtD
Dorzolamide—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000142	0.000639	CcSEcCtD
Dorzolamide—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.000142	0.000639	CcSEcCtD
Dorzolamide—Palpitations—Losartan—type 2 diabetes mellitus	0.000142	0.000638	CcSEcCtD
Dorzolamide—Nausea—Glimepiride—type 2 diabetes mellitus	0.000141	0.000636	CcSEcCtD
Dorzolamide—Arrhythmia—Ramipril—type 2 diabetes mellitus	0.000141	0.000635	CcSEcCtD
Dorzolamide—Loss of consciousness—Losartan—type 2 diabetes mellitus	0.000141	0.000634	CcSEcCtD
Dorzolamide—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000141	0.000634	CcSEcCtD
Dorzolamide—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000141	0.000633	CcSEcCtD
Dorzolamide—Asthenia—Glyburide—type 2 diabetes mellitus	0.000141	0.000633	CcSEcCtD
Dorzolamide—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000141	0.000633	CcSEcCtD
Dorzolamide—Anorexia—Metformin—type 2 diabetes mellitus	0.00014	0.000632	CcSEcCtD
Dorzolamide—Cough—Losartan—type 2 diabetes mellitus	0.00014	0.00063	CcSEcCtD
Dorzolamide—Urticaria—Gliclazide—type 2 diabetes mellitus	0.00014	0.00063	CcSEcCtD
Dorzolamide—Alopecia—Ramipril—type 2 diabetes mellitus	0.00014	0.000628	CcSEcCtD
Dorzolamide—Fatigue—Valsartan—type 2 diabetes mellitus	0.00014	0.000628	CcSEcCtD
Dorzolamide—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000139	0.000627	CcSEcCtD
Dorzolamide—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000139	0.000627	CcSEcCtD
Dorzolamide—Oedema—Irbesartan—type 2 diabetes mellitus	0.000139	0.000626	CcSEcCtD
Dorzolamide—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.000139	0.000626	CcSEcCtD
Dorzolamide—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000139	0.000626	CcSEcCtD
Dorzolamide—Pruritus—Glyburide—type 2 diabetes mellitus	0.000139	0.000625	CcSEcCtD
Dorzolamide—Fatigue—Orlistat—type 2 diabetes mellitus	0.000138	0.00062	CcSEcCtD
Dorzolamide—Hypotension—Metformin—type 2 diabetes mellitus	0.000138	0.00062	CcSEcCtD
Dorzolamide—Erythema—Ramipril—type 2 diabetes mellitus	0.000137	0.000619	CcSEcCtD
Dorzolamide—Shock—Irbesartan—type 2 diabetes mellitus	0.000137	0.000616	CcSEcCtD
Dorzolamide—Pain—Orlistat—type 2 diabetes mellitus	0.000137	0.000615	CcSEcCtD
Dorzolamide—Arthralgia—Losartan—type 2 diabetes mellitus	0.000137	0.000614	CcSEcCtD
Dorzolamide—Chest pain—Losartan—type 2 diabetes mellitus	0.000137	0.000614	CcSEcCtD
Dorzolamide—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000136	0.000614	CcSEcCtD
Dorzolamide—Anxiety—Losartan—type 2 diabetes mellitus	0.000136	0.000612	CcSEcCtD
Dorzolamide—Rash—Bromocriptine—type 2 diabetes mellitus	0.000135	0.000609	CcSEcCtD
Dorzolamide—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000135	0.000608	CcSEcCtD
Dorzolamide—Tension—Ramipril—type 2 diabetes mellitus	0.000135	0.000607	CcSEcCtD
Dorzolamide—Discomfort—Losartan—type 2 diabetes mellitus	0.000135	0.000607	CcSEcCtD
Dorzolamide—Dysgeusia—Ramipril—type 2 diabetes mellitus	0.000135	0.000606	CcSEcCtD
Dorzolamide—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	0.000134	0.000605	CcSEcCtD
Dorzolamide—Headache—Bromocriptine—type 2 diabetes mellitus	0.000134	0.000605	CcSEcCtD
Dorzolamide—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.000134	0.000604	CcSEcCtD
Dorzolamide—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000134	0.000604	CcSEcCtD
Dorzolamide—Nervousness—Ramipril—type 2 diabetes mellitus	0.000134	0.000601	CcSEcCtD
Dorzolamide—Dry mouth—Losartan—type 2 diabetes mellitus	0.000134	0.000601	CcSEcCtD
Dorzolamide—Anorexia—Irbesartan—type 2 diabetes mellitus	0.000133	0.000597	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000132	0.000596	CcSEcCtD
Dorzolamide—Paraesthesia—Metformin—type 2 diabetes mellitus	0.000132	0.000596	CcSEcCtD
Dorzolamide—Confusional state—Losartan—type 2 diabetes mellitus	0.000132	0.000594	CcSEcCtD
Dorzolamide—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000132	0.000593	CcSEcCtD
Dorzolamide—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000131	0.000591	CcSEcCtD
Dorzolamide—Somnolence—Metformin—type 2 diabetes mellitus	0.000131	0.00059	CcSEcCtD
Dorzolamide—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.000131	0.000589	CcSEcCtD
Dorzolamide—Oedema—Losartan—type 2 diabetes mellitus	0.000131	0.000589	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000131	0.000588	CcSEcCtD
Dorzolamide—Hypotension—Irbesartan—type 2 diabetes mellitus	0.00013	0.000585	CcSEcCtD
Dorzolamide—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.00013	0.000584	CcSEcCtD
Dorzolamide—Dyspepsia—Metformin—type 2 diabetes mellitus	0.00013	0.000584	CcSEcCtD
Dorzolamide—Shock—Losartan—type 2 diabetes mellitus	0.000129	0.00058	CcSEcCtD
Dorzolamide—Urticaria—Valsartan—type 2 diabetes mellitus	0.000129	0.000579	CcSEcCtD
Dorzolamide—Decreased appetite—Metformin—type 2 diabetes mellitus	0.000128	0.000577	CcSEcCtD
Dorzolamide—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000128	0.000576	CcSEcCtD
Dorzolamide—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000127	0.000574	CcSEcCtD
Dorzolamide—Fatigue—Metformin—type 2 diabetes mellitus	0.000127	0.000572	CcSEcCtD
Dorzolamide—Urticaria—Orlistat—type 2 diabetes mellitus	0.000127	0.000572	CcSEcCtD
Dorzolamide—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	0.000127	0.00057	CcSEcCtD
Dorzolamide—Hyperhidrosis—Losartan—type 2 diabetes mellitus	0.000127	0.000569	CcSEcCtD
Dorzolamide—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000126	0.000569	CcSEcCtD
Dorzolamide—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000126	0.000569	CcSEcCtD
Dorzolamide—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000126	0.000569	CcSEcCtD
Dorzolamide—Angioedema—Ramipril—type 2 diabetes mellitus	0.000126	0.000565	CcSEcCtD
Dorzolamide—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.000125	0.000562	CcSEcCtD
Dorzolamide—Anorexia—Losartan—type 2 diabetes mellitus	0.000125	0.000561	CcSEcCtD
Dorzolamide—Vomiting—Glyburide—type 2 diabetes mellitus	0.000125	0.000561	CcSEcCtD
Dorzolamide—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000125	0.000561	CcSEcCtD
Dorzolamide—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.000124	0.000558	CcSEcCtD
Dorzolamide—Rash—Glyburide—type 2 diabetes mellitus	0.000124	0.000557	CcSEcCtD
Dorzolamide—Somnolence—Irbesartan—type 2 diabetes mellitus	0.000124	0.000556	CcSEcCtD
Dorzolamide—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000124	0.000556	CcSEcCtD
Dorzolamide—Vertigo—Ramipril—type 2 diabetes mellitus	0.000124	0.000556	CcSEcCtD
Dorzolamide—Syncope—Ramipril—type 2 diabetes mellitus	0.000123	0.000555	CcSEcCtD
Dorzolamide—Headache—Glyburide—type 2 diabetes mellitus	0.000123	0.000553	CcSEcCtD
Dorzolamide—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.000122	0.000551	CcSEcCtD
Dorzolamide—Hypotension—Losartan—type 2 diabetes mellitus	0.000122	0.00055	CcSEcCtD
Dorzolamide—Palpitations—Ramipril—type 2 diabetes mellitus	0.000122	0.000547	CcSEcCtD
Dorzolamide—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.000121	0.000547	CcSEcCtD
Dorzolamide—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.000121	0.000544	CcSEcCtD
Dorzolamide—Loss of consciousness—Ramipril—type 2 diabetes mellitus	0.000121	0.000544	CcSEcCtD
Dorzolamide—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000121	0.000542	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.00012	0.000542	CcSEcCtD
Dorzolamide—Cough—Ramipril—type 2 diabetes mellitus	0.00012	0.00054	CcSEcCtD
Dorzolamide—Fatigue—Irbesartan—type 2 diabetes mellitus	0.00012	0.00054	CcSEcCtD
Dorzolamide—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	0.000119	0.000537	CcSEcCtD
Dorzolamide—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000119	0.000537	CcSEcCtD
Dorzolamide—Pain—Irbesartan—type 2 diabetes mellitus	0.000119	0.000535	CcSEcCtD
Dorzolamide—Insomnia—Losartan—type 2 diabetes mellitus	0.000118	0.000533	CcSEcCtD
Dorzolamide—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000118	0.00053	CcSEcCtD
Dorzolamide—Paraesthesia—Losartan—type 2 diabetes mellitus	0.000118	0.000529	CcSEcCtD
Dorzolamide—Urticaria—Metformin—type 2 diabetes mellitus	0.000117	0.000527	CcSEcCtD
Dorzolamide—Chest pain—Ramipril—type 2 diabetes mellitus	0.000117	0.000527	CcSEcCtD
Dorzolamide—Arthralgia—Ramipril—type 2 diabetes mellitus	0.000117	0.000527	CcSEcCtD
Dorzolamide—Dyspnoea—Losartan—type 2 diabetes mellitus	0.000117	0.000525	CcSEcCtD
Dorzolamide—Anxiety—Ramipril—type 2 diabetes mellitus	0.000117	0.000525	CcSEcCtD
Dorzolamide—Nausea—Glyburide—type 2 diabetes mellitus	0.000117	0.000524	CcSEcCtD
Dorzolamide—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000116	0.000524	CcSEcCtD
Dorzolamide—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000116	0.000524	CcSEcCtD
Dorzolamide—Somnolence—Losartan—type 2 diabetes mellitus	0.000116	0.000524	CcSEcCtD
Dorzolamide—Asthenia—Valsartan—type 2 diabetes mellitus	0.000116	0.000523	CcSEcCtD
Dorzolamide—Discomfort—Ramipril—type 2 diabetes mellitus	0.000116	0.000521	CcSEcCtD
Dorzolamide—Dyspepsia—Losartan—type 2 diabetes mellitus	0.000115	0.000518	CcSEcCtD
Dorzolamide—Asthenia—Orlistat—type 2 diabetes mellitus	0.000115	0.000516	CcSEcCtD
Dorzolamide—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.000115	0.000516	CcSEcCtD
Dorzolamide—Pruritus—Valsartan—type 2 diabetes mellitus	0.000114	0.000515	CcSEcCtD
Dorzolamide—Dry mouth—Ramipril—type 2 diabetes mellitus	0.000114	0.000515	CcSEcCtD
Dorzolamide—Decreased appetite—Losartan—type 2 diabetes mellitus	0.000114	0.000512	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.000114	0.000512	CcSEcCtD
Dorzolamide—Confusional state—Ramipril—type 2 diabetes mellitus	0.000113	0.000509	CcSEcCtD
Dorzolamide—Pruritus—Orlistat—type 2 diabetes mellitus	0.000113	0.000509	CcSEcCtD
Dorzolamide—Fatigue—Losartan—type 2 diabetes mellitus	0.000113	0.000508	CcSEcCtD
Dorzolamide—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	0.000112	0.000505	CcSEcCtD
Dorzolamide—Oedema—Ramipril—type 2 diabetes mellitus	0.000112	0.000505	CcSEcCtD
Dorzolamide—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000112	0.000504	CcSEcCtD
Dorzolamide—Pain—Losartan—type 2 diabetes mellitus	0.000112	0.000504	CcSEcCtD
Dorzolamide—Rash—Gliclazide—type 2 diabetes mellitus	0.000111	0.0005	CcSEcCtD
Dorzolamide—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000111	0.000499	CcSEcCtD
Dorzolamide—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000111	0.000498	CcSEcCtD
Dorzolamide—Urticaria—Irbesartan—type 2 diabetes mellitus	0.00011	0.000497	CcSEcCtD
Dorzolamide—Shock—Ramipril—type 2 diabetes mellitus	0.00011	0.000497	CcSEcCtD
Dorzolamide—Headache—Gliclazide—type 2 diabetes mellitus	0.00011	0.000497	CcSEcCtD
Dorzolamide—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.00011	0.000495	CcSEcCtD
Dorzolamide—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.00011	0.000495	CcSEcCtD
Dorzolamide—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000109	0.000492	CcSEcCtD
Dorzolamide—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	0.000108	0.000488	CcSEcCtD
Dorzolamide—Feeling abnormal—Losartan—type 2 diabetes mellitus	0.000108	0.000485	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	0.000107	0.000482	CcSEcCtD
Dorzolamide—Dizziness—Valsartan—type 2 diabetes mellitus	0.000107	0.000482	CcSEcCtD
Dorzolamide—Anorexia—Ramipril—type 2 diabetes mellitus	0.000107	0.000481	CcSEcCtD
Dorzolamide—Dizziness—Orlistat—type 2 diabetes mellitus	0.000106	0.000476	CcSEcCtD
Dorzolamide—Asthenia—Metformin—type 2 diabetes mellitus	0.000106	0.000476	CcSEcCtD
Dorzolamide—Hypotension—Ramipril—type 2 diabetes mellitus	0.000105	0.000472	CcSEcCtD
Dorzolamide—Nausea—Gliclazide—type 2 diabetes mellitus	0.000105	0.000471	CcSEcCtD
Dorzolamide—Pruritus—Metformin—type 2 diabetes mellitus	0.000104	0.000469	CcSEcCtD
Dorzolamide—Urticaria—Losartan—type 2 diabetes mellitus	0.000104	0.000468	CcSEcCtD
Dorzolamide—Abdominal pain—Losartan—type 2 diabetes mellitus	0.000103	0.000466	CcSEcCtD
Dorzolamide—Body temperature increased—Losartan—type 2 diabetes mellitus	0.000103	0.000466	CcSEcCtD
Dorzolamide—Vomiting—Valsartan—type 2 diabetes mellitus	0.000103	0.000463	CcSEcCtD
Dorzolamide—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000102	0.000461	CcSEcCtD
Dorzolamide—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	0.000102	0.00046	CcSEcCtD
Dorzolamide—Rash—Valsartan—type 2 diabetes mellitus	0.000102	0.000459	CcSEcCtD
Dorzolamide—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000102	0.000459	CcSEcCtD
Dorzolamide—Vomiting—Orlistat—type 2 diabetes mellitus	0.000102	0.000458	CcSEcCtD
Dorzolamide—Insomnia—Ramipril—type 2 diabetes mellitus	0.000101	0.000457	CcSEcCtD
Dorzolamide—Headache—Valsartan—type 2 diabetes mellitus	0.000101	0.000456	CcSEcCtD
Dorzolamide—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000101	0.000454	CcSEcCtD
Dorzolamide—Rash—Orlistat—type 2 diabetes mellitus	0.000101	0.000454	CcSEcCtD
Dorzolamide—Paraesthesia—Ramipril—type 2 diabetes mellitus	0.000101	0.000454	CcSEcCtD
Dorzolamide—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000101	0.000453	CcSEcCtD
Dorzolamide—Headache—Orlistat—type 2 diabetes mellitus	0.0001	0.000451	CcSEcCtD
Dorzolamide—Dyspnoea—Ramipril—type 2 diabetes mellitus	0.0001	0.00045	CcSEcCtD
Dorzolamide—Asthenia—Irbesartan—type 2 diabetes mellitus	9.98e-05	0.000449	CcSEcCtD
Dorzolamide—Somnolence—Ramipril—type 2 diabetes mellitus	9.98e-05	0.000449	CcSEcCtD
Dorzolamide—Dyspepsia—Ramipril—type 2 diabetes mellitus	9.88e-05	0.000445	CcSEcCtD
Dorzolamide—Pruritus—Irbesartan—type 2 diabetes mellitus	9.84e-05	0.000443	CcSEcCtD
Dorzolamide—Decreased appetite—Ramipril—type 2 diabetes mellitus	9.75e-05	0.000439	CcSEcCtD
Dorzolamide—Dizziness—Metformin—type 2 diabetes mellitus	9.74e-05	0.000439	CcSEcCtD
Dorzolamide—Fatigue—Ramipril—type 2 diabetes mellitus	9.67e-05	0.000435	CcSEcCtD
Dorzolamide—Hypersensitivity—Losartan—type 2 diabetes mellitus	9.64e-05	0.000434	CcSEcCtD
Dorzolamide—Nausea—Valsartan—type 2 diabetes mellitus	9.61e-05	0.000433	CcSEcCtD
Dorzolamide—Diarrhoea—Irbesartan—type 2 diabetes mellitus	9.51e-05	0.000428	CcSEcCtD
Dorzolamide—Nausea—Orlistat—type 2 diabetes mellitus	9.5e-05	0.000427	CcSEcCtD
Dorzolamide—Asthenia—Losartan—type 2 diabetes mellitus	9.39e-05	0.000423	CcSEcCtD
Dorzolamide—Vomiting—Metformin—type 2 diabetes mellitus	9.37e-05	0.000422	CcSEcCtD
Dorzolamide—Rash—Metformin—type 2 diabetes mellitus	9.29e-05	0.000418	CcSEcCtD
Dorzolamide—Dermatitis—Metformin—type 2 diabetes mellitus	9.28e-05	0.000418	CcSEcCtD
Dorzolamide—Pruritus—Losartan—type 2 diabetes mellitus	9.26e-05	0.000417	CcSEcCtD
Dorzolamide—Feeling abnormal—Ramipril—type 2 diabetes mellitus	9.25e-05	0.000416	CcSEcCtD
Dorzolamide—Headache—Metformin—type 2 diabetes mellitus	9.23e-05	0.000415	CcSEcCtD
Dorzolamide—Dizziness—Irbesartan—type 2 diabetes mellitus	9.2e-05	0.000414	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	9.18e-05	0.000413	CcSEcCtD
Dorzolamide—Diarrhoea—Losartan—type 2 diabetes mellitus	8.95e-05	0.000403	CcSEcCtD
Dorzolamide—Urticaria—Ramipril—type 2 diabetes mellitus	8.91e-05	0.000401	CcSEcCtD
Dorzolamide—Abdominal pain—Ramipril—type 2 diabetes mellitus	8.87e-05	0.000399	CcSEcCtD
Dorzolamide—Body temperature increased—Ramipril—type 2 diabetes mellitus	8.87e-05	0.000399	CcSEcCtD
Dorzolamide—Vomiting—Irbesartan—type 2 diabetes mellitus	8.84e-05	0.000398	CcSEcCtD
Dorzolamide—Rash—Irbesartan—type 2 diabetes mellitus	8.77e-05	0.000395	CcSEcCtD
Dorzolamide—Dermatitis—Irbesartan—type 2 diabetes mellitus	8.76e-05	0.000394	CcSEcCtD
Dorzolamide—Nausea—Metformin—type 2 diabetes mellitus	8.75e-05	0.000394	CcSEcCtD
Dorzolamide—Headache—Irbesartan—type 2 diabetes mellitus	8.71e-05	0.000392	CcSEcCtD
Dorzolamide—Dizziness—Losartan—type 2 diabetes mellitus	8.65e-05	0.00039	CcSEcCtD
Dorzolamide—Vomiting—Losartan—type 2 diabetes mellitus	8.32e-05	0.000375	CcSEcCtD
Dorzolamide—Hypersensitivity—Ramipril—type 2 diabetes mellitus	8.27e-05	0.000372	CcSEcCtD
Dorzolamide—Nausea—Irbesartan—type 2 diabetes mellitus	8.26e-05	0.000372	CcSEcCtD
Dorzolamide—Rash—Losartan—type 2 diabetes mellitus	8.25e-05	0.000371	CcSEcCtD
Dorzolamide—Dermatitis—Losartan—type 2 diabetes mellitus	8.24e-05	0.000371	CcSEcCtD
Dorzolamide—Headache—Losartan—type 2 diabetes mellitus	8.2e-05	0.000369	CcSEcCtD
Dorzolamide—Asthenia—Ramipril—type 2 diabetes mellitus	8.05e-05	0.000362	CcSEcCtD
Dorzolamide—Pruritus—Ramipril—type 2 diabetes mellitus	7.94e-05	0.000357	CcSEcCtD
Dorzolamide—Nausea—Losartan—type 2 diabetes mellitus	7.77e-05	0.00035	CcSEcCtD
Dorzolamide—Diarrhoea—Ramipril—type 2 diabetes mellitus	7.68e-05	0.000346	CcSEcCtD
Dorzolamide—Dizziness—Ramipril—type 2 diabetes mellitus	7.42e-05	0.000334	CcSEcCtD
Dorzolamide—Vomiting—Ramipril—type 2 diabetes mellitus	7.13e-05	0.000321	CcSEcCtD
Dorzolamide—Rash—Ramipril—type 2 diabetes mellitus	7.08e-05	0.000318	CcSEcCtD
Dorzolamide—Dermatitis—Ramipril—type 2 diabetes mellitus	7.07e-05	0.000318	CcSEcCtD
Dorzolamide—Headache—Ramipril—type 2 diabetes mellitus	7.03e-05	0.000316	CcSEcCtD
Dorzolamide—Nausea—Ramipril—type 2 diabetes mellitus	6.67e-05	0.0003	CcSEcCtD
Dorzolamide—CA5A—Metabolism—PTGS2—type 2 diabetes mellitus	1.94e-05	0.000224	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—PTGS2—type 2 diabetes mellitus	1.94e-05	0.000224	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—APOA1—type 2 diabetes mellitus	1.93e-05	0.000223	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—MTHFR—type 2 diabetes mellitus	1.93e-05	0.000223	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—GSTM1—type 2 diabetes mellitus	1.92e-05	0.000222	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—ALB—type 2 diabetes mellitus	1.92e-05	0.000222	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—AGT—type 2 diabetes mellitus	1.91e-05	0.000221	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—PTGDS—type 2 diabetes mellitus	1.91e-05	0.000221	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—AANAT—type 2 diabetes mellitus	1.91e-05	0.000221	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—PPARA—type 2 diabetes mellitus	1.89e-05	0.000219	CbGpPWpGaD
Dorzolamide—CYP3A4—Biological oxidations—GSTM1—type 2 diabetes mellitus	1.89e-05	0.000218	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—LPL—type 2 diabetes mellitus	1.88e-05	0.000218	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—CALM1—type 2 diabetes mellitus	1.88e-05	0.000217	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—APOE—type 2 diabetes mellitus	1.87e-05	0.000216	CbGpPWpGaD
Dorzolamide—CYP3A4—Metapathway biotransformation—GSTM1—type 2 diabetes mellitus	1.86e-05	0.000215	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—APOA1—type 2 diabetes mellitus	1.85e-05	0.000214	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—ADCY5—type 2 diabetes mellitus	1.84e-05	0.000213	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—GPX1—type 2 diabetes mellitus	1.84e-05	0.000212	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—PIK3R1—type 2 diabetes mellitus	1.84e-05	0.000212	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—NOS3—type 2 diabetes mellitus	1.84e-05	0.000212	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—AGT—type 2 diabetes mellitus	1.83e-05	0.000212	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—CPT1A—type 2 diabetes mellitus	1.82e-05	0.00021	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—PTGS2—type 2 diabetes mellitus	1.81e-05	0.000209	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—PTGS2—type 2 diabetes mellitus	1.81e-05	0.000209	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—CDO1—type 2 diabetes mellitus	1.81e-05	0.000209	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—GPD2—type 2 diabetes mellitus	1.81e-05	0.000209	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—CALM1—type 2 diabetes mellitus	1.8e-05	0.000208	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—APOE—type 2 diabetes mellitus	1.8e-05	0.000208	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—CD36—type 2 diabetes mellitus	1.79e-05	0.000207	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—APOA1—type 2 diabetes mellitus	1.78e-05	0.000205	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—LIPC—type 2 diabetes mellitus	1.77e-05	0.000204	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—PPP2CA—type 2 diabetes mellitus	1.77e-05	0.000204	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—type 2 diabetes mellitus	1.76e-05	0.000203	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—AK1—type 2 diabetes mellitus	1.73e-05	0.0002	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—CETP—type 2 diabetes mellitus	1.71e-05	0.000197	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—PPARG—type 2 diabetes mellitus	1.7e-05	0.000197	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—MTHFR—type 2 diabetes mellitus	1.7e-05	0.000196	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—PTGS2—type 2 diabetes mellitus	1.68e-05	0.000194	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—INS—type 2 diabetes mellitus	1.67e-05	0.000193	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—PPARA—type 2 diabetes mellitus	1.66e-05	0.000192	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—PPARG—type 2 diabetes mellitus	1.63e-05	0.000189	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—AGT—type 2 diabetes mellitus	1.61e-05	0.000186	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—INS—type 2 diabetes mellitus	1.6e-05	0.000185	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—MAT1A—type 2 diabetes mellitus	1.59e-05	0.000184	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—SLC5A4—type 2 diabetes mellitus	1.59e-05	0.000184	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—SREBF1—type 2 diabetes mellitus	1.59e-05	0.000183	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—CALM1—type 2 diabetes mellitus	1.58e-05	0.000183	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—APOE—type 2 diabetes mellitus	1.58e-05	0.000182	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—PPARG—type 2 diabetes mellitus	1.56e-05	0.000181	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—APOA1—type 2 diabetes mellitus	1.56e-05	0.00018	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—type 2 diabetes mellitus	1.56e-05	0.00018	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—HMGCR—type 2 diabetes mellitus	1.54e-05	0.000178	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—ND1—type 2 diabetes mellitus	1.54e-05	0.000178	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—G6PC—type 2 diabetes mellitus	1.54e-05	0.000178	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—PPP1R3C—type 2 diabetes mellitus	1.54e-05	0.000178	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—ENPP1—type 2 diabetes mellitus	1.54e-05	0.000178	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—HBA2—type 2 diabetes mellitus	1.54e-05	0.000178	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—INS—type 2 diabetes mellitus	1.53e-05	0.000177	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—ALB—type 2 diabetes mellitus	1.53e-05	0.000177	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—GCGR—type 2 diabetes mellitus	1.49e-05	0.000172	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—ALB—type 2 diabetes mellitus	1.47e-05	0.00017	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—NOS3—type 2 diabetes mellitus	1.46e-05	0.000169	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—PIK3R1—type 2 diabetes mellitus	1.46e-05	0.000169	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—BHMT—type 2 diabetes mellitus	1.44e-05	0.000167	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—type 2 diabetes mellitus	1.44e-05	0.000166	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—CYTB—type 2 diabetes mellitus	1.41e-05	0.000163	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—OXCT1—type 2 diabetes mellitus	1.41e-05	0.000163	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—ALB—type 2 diabetes mellitus	1.41e-05	0.000163	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—NOS3—type 2 diabetes mellitus	1.4e-05	0.000162	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—PIK3R1—type 2 diabetes mellitus	1.4e-05	0.000162	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—PPARG—type 2 diabetes mellitus	1.38e-05	0.000159	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—SRD5A1—type 2 diabetes mellitus	1.37e-05	0.000159	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—INS—type 2 diabetes mellitus	1.35e-05	0.000156	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—PIK3R1—type 2 diabetes mellitus	1.35e-05	0.000156	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—NOS3—type 2 diabetes mellitus	1.35e-05	0.000156	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—PTGS2—type 2 diabetes mellitus	1.34e-05	0.000155	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—HSD17B3—type 2 diabetes mellitus	1.31e-05	0.000151	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—STAR—type 2 diabetes mellitus	1.31e-05	0.000151	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—ACACA—type 2 diabetes mellitus	1.31e-05	0.000151	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—PTGS2—type 2 diabetes mellitus	1.28e-05	0.000148	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PTGDS—type 2 diabetes mellitus	1.26e-05	0.000146	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—AANAT—type 2 diabetes mellitus	1.26e-05	0.000146	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—CBS—type 2 diabetes mellitus	1.25e-05	0.000145	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—ABCC8—type 2 diabetes mellitus	1.25e-05	0.000145	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—ALB—type 2 diabetes mellitus	1.24e-05	0.000143	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—PTGS2—type 2 diabetes mellitus	1.23e-05	0.000142	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—COX2—type 2 diabetes mellitus	1.21e-05	0.00014	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—SLC5A2—type 2 diabetes mellitus	1.21e-05	0.00014	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—CDO1—type 2 diabetes mellitus	1.19e-05	0.000138	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—GPD2—type 2 diabetes mellitus	1.19e-05	0.000138	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—NCOA6—type 2 diabetes mellitus	1.19e-05	0.000137	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	1.19e-05	0.000137	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—PIK3R1—type 2 diabetes mellitus	1.18e-05	0.000137	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—NOS3—type 2 diabetes mellitus	1.18e-05	0.000137	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—HSD11B1—type 2 diabetes mellitus	1.17e-05	0.000135	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—UCP2—type 2 diabetes mellitus	1.17e-05	0.000135	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—UCP3—type 2 diabetes mellitus	1.17e-05	0.000135	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—AK1—type 2 diabetes mellitus	1.14e-05	0.000132	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	1.13e-05	0.000131	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—PCK1—type 2 diabetes mellitus	1.1e-05	0.000127	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—PTGS2—type 2 diabetes mellitus	1.08e-05	0.000125	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	1.08e-05	0.000125	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	1.05e-05	0.000122	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—SLC5A4—type 2 diabetes mellitus	1.05e-05	0.000121	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—MAT1A—type 2 diabetes mellitus	1.05e-05	0.000121	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—HK1—type 2 diabetes mellitus	1.03e-05	0.000119	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	1.03e-05	0.000119	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—HBA2—type 2 diabetes mellitus	1.02e-05	0.000117	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PPP1R3C—type 2 diabetes mellitus	1.02e-05	0.000117	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—G6PC—type 2 diabetes mellitus	1.02e-05	0.000117	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—ND1—type 2 diabetes mellitus	1.02e-05	0.000117	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—ENPP1—type 2 diabetes mellitus	1.02e-05	0.000117	CbGpPWpGaD
Dorzolamide—CA14—Metabolism—AKT1—type 2 diabetes mellitus	1e-05	0.000116	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—LPA—type 2 diabetes mellitus	9.92e-06	0.000115	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—GCKR—type 2 diabetes mellitus	9.92e-06	0.000115	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—KCNJ11—type 2 diabetes mellitus	9.92e-06	0.000115	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—HSD3B2—type 2 diabetes mellitus	9.92e-06	0.000115	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—GCGR—type 2 diabetes mellitus	9.83e-06	0.000114	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—AKT1—type 2 diabetes mellitus	9.76e-06	0.000113	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—AKT1—type 2 diabetes mellitus	9.76e-06	0.000113	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	9.54e-06	0.00011	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—ALDOB—type 2 diabetes mellitus	9.51e-06	0.00011	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—CYTB—type 2 diabetes mellitus	9.28e-06	0.000107	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—OXCT1—type 2 diabetes mellitus	9.28e-06	0.000107	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	9.24e-06	0.000107	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—AKT1—type 2 diabetes mellitus	9.11e-06	0.000105	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—AKT1—type 2 diabetes mellitus	9.11e-06	0.000105	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	9.05e-06	0.000105	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—SRD5A1—type 2 diabetes mellitus	9.05e-06	0.000105	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	8.95e-06	0.000103	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—GLP1R—type 2 diabetes mellitus	8.84e-06	0.000102	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	8.63e-06	9.97e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	8.63e-06	9.97e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	8.63e-06	9.97e-05	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—AKT1—type 2 diabetes mellitus	8.44e-06	9.75e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	8.27e-06	9.56e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	8.27e-06	9.56e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—SLC2A2—type 2 diabetes mellitus	8.25e-06	9.54e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—CPT1A—type 2 diabetes mellitus	8.08e-06	9.34e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—MTR—type 2 diabetes mellitus	8.08e-06	9.34e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	7.96e-06	9.21e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	7.96e-06	9.21e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—NAMPT—type 2 diabetes mellitus	7.93e-06	9.16e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	7.88e-06	9.11e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—LIPC—type 2 diabetes mellitus	7.88e-06	9.11e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—HBA1—type 2 diabetes mellitus	7.88e-06	9.11e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—GCK—type 2 diabetes mellitus	7.88e-06	9.11e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—CYP11A1—type 2 diabetes mellitus	7.83e-06	9.05e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	7.82e-06	9.04e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	7.69e-06	8.89e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	7.69e-06	8.89e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	7.69e-06	8.89e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—SLC9A1—type 2 diabetes mellitus	7.69e-06	8.89e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—CETP—type 2 diabetes mellitus	7.6e-06	8.79e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	7.23e-06	8.36e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	7.09e-06	8.19e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—PSMD6—type 2 diabetes mellitus	7.07e-06	8.17e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—SNAP25—type 2 diabetes mellitus	7.07e-06	8.17e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—SREBF1—type 2 diabetes mellitus	7.07e-06	8.17e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—CTGF—type 2 diabetes mellitus	6.94e-06	8.02e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—HMGCR—type 2 diabetes mellitus	6.87e-06	7.95e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	6.78e-06	7.84e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	6.77e-06	7.83e-05	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—AKT1—type 2 diabetes mellitus	6.73e-06	7.78e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—ADRA2A—type 2 diabetes mellitus	6.73e-06	7.78e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	6.54e-06	7.56e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	6.54e-06	7.56e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	6.54e-06	7.56e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	6.54e-06	7.56e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—CYP2E1—type 2 diabetes mellitus	6.46e-06	7.47e-05	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—AKT1—type 2 diabetes mellitus	6.45e-06	7.46e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—SLC2A1—type 2 diabetes mellitus	6.39e-06	7.39e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—CYP1A2—type 2 diabetes mellitus	6.39e-06	7.39e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	6.27e-06	7.25e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—CYP3A4—type 2 diabetes mellitus	6.23e-06	7.2e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	6.2e-06	7.17e-05	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—AKT1—type 2 diabetes mellitus	6.18e-06	7.15e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—GCG—type 2 diabetes mellitus	6.13e-06	7.08e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—SLC2A4—type 2 diabetes mellitus	6.13e-06	7.08e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	5.83e-06	6.74e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	5.44e-06	6.29e-05	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—AKT1—type 2 diabetes mellitus	5.44e-06	6.28e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	5.33e-06	6.16e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	5.33e-06	6.16e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—PPARGC1A—type 2 diabetes mellitus	5.28e-06	6.1e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—GNB3—type 2 diabetes mellitus	5.28e-06	6.1e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—HMOX1—type 2 diabetes mellitus	5.26e-06	6.08e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	5.23e-06	6.04e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	5.2e-06	6.01e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	5.2e-06	6.01e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	5.2e-06	6.01e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—CAT—type 2 diabetes mellitus	5.19e-06	5.99e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	5.16e-06	5.97e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	5.07e-06	5.86e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—APOB—type 2 diabetes mellitus	5.04e-06	5.82e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	5.01e-06	5.79e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—GSTM1—type 2 diabetes mellitus	4.9e-06	5.66e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—LPL—type 2 diabetes mellitus	4.81e-06	5.56e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—ADCY5—type 2 diabetes mellitus	4.71e-06	5.44e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—GPX1—type 2 diabetes mellitus	4.69e-06	5.42e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	4.66e-06	5.39e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	4.66e-06	5.39e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	4.66e-06	5.39e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	4.57e-06	5.29e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—CD36—type 2 diabetes mellitus	4.57e-06	5.28e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	4.53e-06	5.24e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—PPP2CA—type 2 diabetes mellitus	4.51e-06	5.21e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	4.44e-06	5.13e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—MTHFR—type 2 diabetes mellitus	4.33e-06	5e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	4.26e-06	4.93e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—PPARA—type 2 diabetes mellitus	4.25e-06	4.91e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	4.21e-06	4.87e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	4.21e-06	4.87e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—AGT—type 2 diabetes mellitus	4.11e-06	4.75e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—CALM1—type 2 diabetes mellitus	4.04e-06	4.67e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	4.04e-06	4.67e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	4.04e-06	4.67e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—APOE—type 2 diabetes mellitus	4.03e-06	4.66e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—APOA1—type 2 diabetes mellitus	3.98e-06	4.6e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—PPARG—type 2 diabetes mellitus	3.51e-06	4.06e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	3.48e-06	4.03e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.48e-06	4.03e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	3.47e-06	4.01e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—INS—type 2 diabetes mellitus	3.44e-06	3.98e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	3.42e-06	3.95e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	3.32e-06	3.84e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	3.23e-06	3.73e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	3.17e-06	3.66e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—ALB—type 2 diabetes mellitus	3.16e-06	3.65e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	3.1e-06	3.59e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	3.09e-06	3.58e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—NOS3—type 2 diabetes mellitus	3.02e-06	3.49e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—PIK3R1—type 2 diabetes mellitus	3.02e-06	3.49e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	3.01e-06	3.48e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	2.98e-06	3.44e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	2.86e-06	3.3e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	2.8e-06	3.24e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—PTGS2—type 2 diabetes mellitus	2.76e-06	3.19e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	2.71e-06	3.14e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	2.67e-06	3.08e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	2.66e-06	3.07e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	2.63e-06	3.04e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	2.32e-06	2.68e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	2.27e-06	2.62e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	2.08e-06	2.41e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	1.99e-06	2.3e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	1.99e-06	2.3e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	1.82e-06	2.1e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—AKT1—type 2 diabetes mellitus	1.39e-06	1.6e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	9.15e-07	1.06e-05	CbGpPWpGaD
